Crystal Amber Fund Ltd.

1. 01 Oct 26
   Appointment of Non-Executive Director

   ("Crystal Amber Fund", the "Fund" or the "Company")

   RNS 9800247 ↗
2. 03 Aug 26
   Update on MMI and Further Investment

   ("Crystal Amber Fund", the "Fund" or the "Company")

   RNS 9701813 ↗
3. 01 Jul 26
   Appointment of NOMAD and Broker

   ("Crystal Amber Fund", the "Fund" or the "Company")

   RNS 9645701 ↗
4. 06 May 26
   Purchase of Ordinary Shares by Tarncourt

   Further to the announcement on 31 March 2026 regarding the intended share purchase by Tarncourt Capital Limited ("Tarncourt"), the owner of the Company's new Investment Adviser, Tarncourt Asset Management Ltd, the Company has been notified that Tarncourt...

   RNS 9555198 ↗
5. 22 Apr 26
   Result of General Meeting

   The Company announces that at the Extraordinary General Meeting held earlier today, all resolutions set out in the circular to shareholders dated 31 March 2026 (the "Circular") were duly passed.

   RNS 9532731 ↗
6. 02 Apr 26
   Director/PDMR Shareholding Director buysActivist stake

   ("Crystal Amber Fund", the "Company" or the "Fund")

   RNS 9506185 ↗
7. 01 Apr 26
   Director/PDMR Shareholding Director buysActivist stake

   Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities The Company has been notified that 20,000 Ordinary Shares in the Company have been acquired by Mr Christopher Waldron, Chairman of the Company.

   RNS 9504255 ↗
8. 31 Mar 26
   Half-year Results

   For the six months ended 31 December 2025

   RNS 9499393 ↗
9. 16 Feb 26
   Update on Morphic Medical Inc.

   The Board of Crystal Amber is pleased to provide an update on Morphic Medical Inc.

   RNS 9433178 ↗
10. 16 Jan 26
    Update and corrections regarding TVRs

    The following announcement replaces the 'Update and corrections regarding total voting rights' announcement released on 16 January 2026 at 7:00 under RNS Number 1452P.

    RNS 9359391 ↗
11. 16 Jan 26
    Update & corrections regarding total voting rights

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9357565 ↗
12. 12 Jan 26
    Cancellation of treasury shares

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9348603 ↗
13. 11 Dec 25
    Director/PDMR Shareholding Director buysActivist stake

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9289249 ↗
14. 03 Dec 25
    Share Buyback Programme Buyback

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9273071 ↗
15. 20 Nov 25
    Share Buyback Programme Buyback

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9245500 ↗
16. 17 Nov 25
    Holding(s) in Company Activist stake

    TR-1: Standard form for notification of major holdings

    RNS 9239406 ↗
17. 14 Nov 25
    Proposed change of strategy and investment manager

    596/2014 to the extent it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended by virtue of the European Union (Withdrawal Agreement) Act 2020).

    RNS 9233229 ↗
18. 20 Oct 25
    Share Buyback Programme Buyback

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9181768 ↗
19. 17 Oct 25
    Final Results

    Final results for the year ended 30 June 2025

    RNS 9176742 ↗
20. 16 Oct 25
    Investor Presentation by Morphic Medical Inc

    The Board of Crystal Amber is pleased to announce that Morphic Medical Inc.

    RNS 9174190 ↗
21. 07 Oct 25
    Investor Presentation by Morphic Medical Inc

    ("Crystal Amber Fund", the "Company" or the "Fund")

    RNS 9154315 ↗

Source: Investegate RNS archive. Quotes are short extracts. Not investment advice.